Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

AtriCure Q3 Adj. EPS $(0.01) Beats $(0.12) Estimate, Sales $134.269M Beat $131.254M Estimate

Author: Benzinga Newsdesk | October 29, 2025 03:01pm
AtriCure (NASDAQ:ATRC) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.12) by 91.3 percent. This is a 94.12 percent increase over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $134.269 million which beat the analyst consensus estimate of $131.254 million by 2.30 percent. This is a 15.84 percent increase over sales of $115.910 million the same period last year.

Posted In: ATRC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist